Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

NCT00968708 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5380

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Acute Coronary Syndrome

Interventions

DRUG: Alogliptin
DRUG: Placebo

Sponsor

Takeda